Amended Statement of Ownership (sc 13g/a)
January 27 2021 - 3:04PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE
13G/A
Under the Securities Exchange Act of
1934
(Amendment No. 5)*
PLANDAI
BIOTECHNOLOGY, INC.
(Name of Issuer)
Common
Stock $0.0001 par value
(Title of Class of Securities)
72703D100
(CUSIP Number)
December
31, 2020
(Date of Event which Requires Filing of
this Statement)
Check the appropriate box to designate
the rule pursuant to which this Schedule is filed:
* The remainder of this cover page shall be filled out for a
reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment
containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page
shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
|
CUSIP No. 72703D100
|
13G/A
|
Page 2 of 7 Pages
|
|
1.
|
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
EMA Financial, LLC
|
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a) ☐
(b) ☒
|
|
3.
|
SEC USE ONLY
|
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5.
|
SOLE VOTING POWER
0
|
|
6.
|
SHARED VOTING POWER
300,931,290
|
|
7.
|
SOLE DISPOSITIVE POWER
0
|
|
8.
|
SHARED DISPOSITIVE POWER
300,931,290
|
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
300,931,290
|
|
10.
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) ☐
|
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.9%
|
|
12.
|
TYPE OF REPORTING PERSON (see instructions)
OO
|
|
CUSIP No. 72703D100
|
13G/A
|
Page 3 of 7 Pages
|
|
1.
|
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
EMA Group, LLC
|
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a) ☐
(b) ☒
|
|
3.
|
SEC USE ONLY
|
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5.
|
SOLE VOTING POWER
0
|
|
6.
|
SHARED VOTING POWER
300,931,290
|
|
7.
|
SOLE DISPOSITIVE POWER
0
|
|
8.
|
SHARED DISPOSITIVE POWER
300,931,290
|
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
300,931,290
|
|
10.
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) ☐
|
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.9%
|
|
12.
|
TYPE OF REPORTING PERSON (see instructions)
OO
|
|
CUSIP No. 72703D100
|
13G/A
|
Page 4 of 7 Pages
|
|
1.
|
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Felicia Preston
|
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a) ☐
(b) ☒
|
|
3.
|
SEC USE ONLY
|
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
New York
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5.
|
SOLE VOTING POWER
0
|
|
6.
|
SHARED VOTING POWER
300,931,290
|
|
7.
|
SOLE DISPOSITIVE POWER
0
|
|
8.
|
SHARED DISPOSITIVE POWER
300,931,290
|
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
300,931,290
|
|
10.
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) ☐
|
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.9%
|
|
12.
|
TYPE OF REPORTING PERSON (see instructions)
IN
|
|
CUSIP No. 72703D100
|
13G/A
|
Page 5 of 7 Pages
|
Item 4. Ownership.
Provide the following information regarding the aggregate number
and percentage of the class of securities of the issuer identified in Item 1.
|
|
(a)
|
Amount beneficially owned: 300,931,290* shares of Common Stock as of January 24, 2020.
|
|
|
(b)
|
Percent of class:
9.9%
|
The Reporting Persons’ beneficial ownership
of 300,931,290* shares of Common Stock constitutes 9.9%* of all the outstanding shares of Common Stock, based upon 3,039,710,000
shares of Common Stock outstanding as of January 24, 2021, as reported by the Issuer’s Transfer Agent to OTCMarkets.
|
|
(c)
|
Number of shares as to which the person has:
|
|
|
(i)
|
Sole power to vote or to direct the vote of 0.
|
|
|
(ii)
|
Shared power to vote or to direct the vote 300,931,290*.
|
|
|
(iii)
|
Sole power to dispose or to direct the disposition of 0.
|
|
|
(iv)
|
Shared power to dispose or to direct the disposition of 300,931,290*.
|
* EMA Financial, LLC owns a convertible note (“Note”)
which is convertible into shares of Common Stock pursuant to the terms of the Note, which conversions is limited pursuant to the
Ownership Limitation (defined below). In accordance with Rule 13d-4 under the Securities Exchange Act of 1934, as amended, because
the number of shares of Common Stock into which the Notes are convertible is limited, pursuant to the terms of such instruments,
to that number of shares of Common Stock which would result in the Reporting Persons having beneficial ownership of 9.9% of the
total issued and outstanding shares of Common Stock (the “Ownership Limitation”), the Reporting Persons disclaim beneficial
ownership of any and all shares of Common Stock that would cause any Reporting Person’s beneficial ownership to exceed the Ownership
Limitation.
EMA Group, LLC (“EMA Group”) is the investment
manager of EMA Financial, LLC (“EMA”), and Felicia Preston (“Preston”) is the managing member of EMA Group.
Therefore, each of EMA Group and Preston may be deemed to have voting and investment power over the securities. Each of EMA Group
and Preston expressly disclaims any equitable or beneficial ownership of such securities.
Instruction. For computations regarding securities which
represent a right to acquire an underlying security see §240.13d-3(d)(1).
Item 5. Ownership of Five Percent
or Less of a Class.
If this statement is being filed to report the fact that as
of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities,
check the following ☐.
Instruction. Dissolution of a group requires a response
to this item.
|
CUSIP No. 72703D100
|
13G/A
|
Page 6 of 7 Pages
|
Item 6. Ownership of More than
Five Percent on Behalf of Another Person.
Not Applicable
Item 7. Identification and
Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
Not Applicable
Item 8. Identification and
Classification of Members of the Group.
Not Applicable.
Item 9. Notice of
Dissolution of Group.
Not Applicable.
Item 10. Certification.
|
|
(a)
|
The following certification shall be included if the statement is filed pursuant to §240.13d-1(b):
|
By signing below I certify that, to the best of my
knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not
acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities
and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
|
|
(b)
|
The following certification shall be included if the statement is filed pursuant to §240.13d-1(c):
|
By signing below I certify that, to the best of my
knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect
of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with
or as a participant in any transaction having that purpose or effect.
|
CUSIP No. 72703D100
|
13G/A
|
Page 7 of 7 Pages
|
After reasonable inquiry and to the best
of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
1/25/2021
|
|
|
Date
|
|
|
|
|
|
/s/ Felicia Preston
|
|
|
Signature
|
|
|
|
|
|
Felicia Preston/Director
|
|
|
Name/Title
|
Plandai Biotechnology (PK) (USOTC:PLPL)
Historical Stock Chart
From Nov 2024 to Dec 2024
Plandai Biotechnology (PK) (USOTC:PLPL)
Historical Stock Chart
From Dec 2023 to Dec 2024
